Rayonier RYN Issuance of common stock and replacement awards in connection with Oclaro acquisition

Issuance of common stock and replacement awards in connection with Oclaro acquisition at other companies

Karman Holdings Inc.KRMN

$15.21M+424%

Hims & Hers HealthHIMS

$0-100%

Kratos Defense & Security SolutionsKTOS

$88.8M+176%

IonQIONQ

$164.65M—

ServiceNowNOW

$475.25M—

SynopsysSNPS

$4.28B—

Other financials

Income statement

See full

Revenue$276.8M+234%

Gross profit$46.5M+158%

Operating income-$45.7M-77,478%

Net income-$12.4M-263%

EPS (diluted)-$0.05-150%

Balance sheet

See full

Cash & equivalents$681.7M+215%

Total debt$2.3B+82.2%

Total equity$5.3B+178%

Total assets$7.7B+131%

Cash flow

See full

Operating cash flow$34.6M+24.9%

CapEx$4.9M+28.6%

Free cash flow$29.7M+24.3%

Valuation

See full

Market cap$6.31B+43.2%

Enterprise value$7.92B+45.4%

P/E13.6×+1.1×

P/S9.3×+4.7×

Profitability

See full

Gross margin27.4%-17.6pp

Operating margin5.5%-31.6pp

Net margin68.6%+31.6pp

FCF margin37.9%+19.9pp

Returns & leverage

See full

Return on equity12.8%-6.1pp

Debt / equity0.4×-0.2×

Current ratio2.5×-0.2×

Where this comes from

Reported directly by Rayonier in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable.

The official record: Rayonier’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rayonier's issuance of common stock and replacement awards in connection with oclaro acquisition.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rayonier's issuance of common stock and replacement awards in connection with oclaro acquisition?: Rayonier (RYN) reported issuance of common stock and replacement awards in connection with oclaro acquisition of $3.23B in Q1 2026.